Processa Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Processa Pharmaceuticals Inc are displayed. Full Sustainability analysis of Processa Pharmaceuticals Inc are accessed by registering for free. The report of Processa Pharmaceuticals Inc is prepared by All Street Sevva using leading Cognitive Robots.
Processa Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 1.6, social score of 6.0 and governance score of 6.0.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | Processa Pharmaceuticals Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Processa Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Processa Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Processa Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Processa Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Processa Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Processa Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Processa Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Processa Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase 2A clinical trials for the treatment of gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia; PCS3117, a cytosine analog, which is in Phase 2B clinical trials for the treatment of pancreatic and non-small cell lung cancer; and PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase that is in Phase 1B clinical trials for treating metastatic colorectal and breast cancer. In addition, it develops PCS11T, an analog of SN38 and irinotecan drug for the treatment of various cancers. The company was incorporated in 2011 and is based in Hanover, Maryland.